TAREG Side Effects

7021104-3 | Folate Deficiency, Pernicious Anaemia
on Sep 08, 2010 Female patient from FRANCE , 90 years of age, was diagnosed with hypertension and was treated with Tareg (View Usage). Patient experienced the following unwanted or unexpected effects: folate deficiency, pernicious anaemia. Tareg dosage: 80 Mg, Qd.

7001119-1 | Anaemia, Antinuclear Antibody Positive, Arthralgia, Dna Antibody Positive, Fatigue, Haemolytic Anaemia, Muscle Spasms, Oedema Peripheral, Psoriasis
Patient was taking Tareg (View Usage). Patient had the following side effects: anaemia, antinuclear antibody positive, arthralgia, dna antibody positive, fatigue, haemolytic anaemia, muscle spasms, oedema peripheral, psoriasis on Sep 08, 2010 from FRANCE Additional patient health information: Female patient , weighting 154.3 lb, was diagnosed with hypertension and. Tareg dosage: 160 Mg, (1 Df Daily). Patient was hospitalized.

6970250-9 | Folate Deficiency, Pernicious Anaemia
Adverse event was reported on Aug 25, 2010 by a Female patient taking Tareg (View Usage) (Dosage: 80 Mg, Qd) was diagnosed with hypertension and. Location: FRANCE , 90 years of age, After Tareg was administered, patient had the following side effects: folate deficiency, pernicious anaemia.

6961644-6 | Abdominal Pain Upper, Anxiety, Panic Attack, Syncope, Tremor
on Aug 19, 2010 Male patient from ITALY , 20 years of age, was diagnosed with hypertension and was treated with Tareg (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, anxiety (What is anxiety?), panic attack, syncope, tremor. Tareg dosage: 40 Mg Daily.


6939102-4 | Bone Marrow Failure, Erythroblastosis, Granulocyte Count Decreased, Megakaryocytes Abnormal, Neutropenia, Thrombocytopenia
on Aug 10, 2010 Female patient from FRANCE , 69 years of age, was diagnosed with chronic myeloid leukaemia, parkinson's disease (What is parkinson's disease?) and was treated with Tareg (View Usage). Patient had the following side effects: bone marrow failure, erythroblastosis, granulocyte count decreased, megakaryocytes abnormal, neutropenia, thrombocytopenia. Tareg dosage: 80 Mg, Unk. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), GLEEVEC (Unk) (View Gleevec Review and Gleevec Label ), SINEMET (200 Mg, Unk) (View Sinemet Review and Sinemet Label ), MODOPAR (Unk) (View Modopar Review and Modopar Label ), MOTILIUM (View Motilium Review and Motilium Label ), CRESTOR (View Crestor Review and Crestor Label ), FORLAX (View Forlax Review and Forlax Label ), DEDROGYL (View Dedrogyl Review and Dedrogyl Label ).

6843796-1 | Face Oedema, Laryngeal Oedema, Urticaria
Patient was taking Tareg (View Usage). After Tareg was administered, patient had the following side effects: face oedema, laryngeal oedema, urticaria on Jul 01, 2010 from FRANCE Additional patient health information: Male patient , weighting 260.1 lb, was diagnosed with hypertension and. Tareg dosage: 160 Mg, Qd. During the same period patient was treated with ALDACTONE (50 Mg/day) (View Aldactone Review and Aldactone Label ), CALDINE (6 Mg/day) (View Caldine Review and Caldine Label ), HYPERIUM (1 Mg, Bid) (View Hyperium Review and Hyperium Label ), GLUCOPHAGE (850 Mg, Bid) (View Glucophage Review and Glucophage Label ), CELECTOL (100 Mg/ Day) (View Celectol Review and Celectol Label ).

6839324-7 | Cataract Operation
Adverse event was reported on Jul 01, 2010 by a Female patient taking Tareg (View Usage) (Dosage: 160 Mg, Qd) was diagnosed with hypertension and. Location: CHILE , 93 years of age, Patient experienced the following unwanted or unexpected effects: cataract operation. During the same period patient was treated with GLAFORNIL (Unk) (View Glafornil Review and Glafornil Label ).

6816487-0 | Laryngeal Oedema, Urticaria
on Jun 22, 2010 Male patient from FRANCE , 75 years of age, was diagnosed with hypertension and was treated with Tareg (View Usage). Patient had the following side effects: laryngeal oedema, urticaria. Tareg dosage: 160 Mg, Qd. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), CALDINE (View Caldine Review and Caldine Label ), HYPERIUM (View Hyperium Review and Hyperium Label ), GLUCOPHAGE (Unk) (View Glucophage Review and Glucophage Label ).

6784766-1 | Dementia, Fall, Head Injury, Malaise, Orthostatic Hypotension, Osteoarthritis
on Jun 09, 2010 Female patient from FRANCE , 79 years of age, was treated with Tareg (View Usage). After Tareg was administered, patient had the following side effects: dementia (What is dementia?), fall (What is fall?), head injury, malaise, orthostatic hypotension, osteoarthritis (What is osteoarthritis?). Tareg dosage: 60 Mg Daily. During the same period patient was treated with MONICOR L.P. (20 Mg Daily) (View Monicor L.p. Review and Monicor L.p. Label ), LASIX (40 Mg Daily) (View Lasix Review and Lasix Label ), RISPERDAL (0.5 Mg Daily) (View Risperdal Review and Risperdal Label ), SOTALOL (View Sotalol Review and Sotalol Label ), VASTAREL (2 Df Daily) (View Vastarel Review and Vastarel Label ). Patient was hospitalized.

6721610-2 | Dementia With Lewy Bodies, Fall, Humerus Fracture, Immobilisation Prolonged, Lymphoma
Patient was taking Tareg (View Usage). Patient experienced the following unwanted or unexpected effects: dementia with lewy bodies, fall (What is fall?), humerus fracture, immobilisation prolonged, lymphoma (What is lymphoma?) on Apr 29, 2010 from FRANCE Additional patient health information: Female patient , 81 years of age, . Tareg dosage: 160 Mg, Qd. During the same period patient was treated with LOXEN LP (50 Mg, Qd) (View Loxen Lp Review and Loxen Lp Label ), ZOLPIDEM (Unk) (View Zolpidem Review and Zolpidem Label ), DIAMICRON (60 Mg Daily) (View Diamicron Review and Diamicron Label ), TANAKAN (Unk) (View Tanakan Review and Tanakan Label ), PARACETAMOL (Unk) (View Paracetamol Review and Paracetamol Label ), ACTONEL (Unk) (View Actonel Review and Actonel Label ), ORAL ANTIDIABETICS (Unk) (View Oral Antidiabetics Review and Oral Antidiabetics Label ). Patient was hospitalized.

6711533-7 | Lung Disorder, Renal Failure Acute
Adverse event was reported on Apr 21, 2010 by a Female patient taking Tareg (View Usage) (Dosage: 80 Mg Daily) was diagnosed with hypertension, type 2 diabetes mellitus, depression (What is depression?), anxiety (What is anxiety?), insomnia and. Location: FRANCE , 82 years of age, Patient had the following side effects: lung disorder, renal failure acute. During the same period patient was treated with METFORMIN HCL (1700 Mg) (View Metformin Hcl Review and Metformin Hcl Label ), GLICLAZIDE (2 Df Daily) (View Gliclazide Review and Gliclazide Label ), FUROSEMIDE (1 Df Daily) (View Furosemide Review and Furosemide Label ), LOPERAMIDE HCL (View Loperamide Hcl Review and Loperamide Hcl Label ), ESCITALOPRAM (View Escitalopram Review and Escitalopram Label ), MIANSERIN HYDROCHLORIDE (View Mianserin Hydrochloride Review and Mianserin Hydrochloride Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), MEPRONIZINE (View Mepronizine Review and Mepronizine Label ). Patient was hospitalized.

6709366-0 | Loss Of Consciousness, Malaise, Orthostatic Hypotension
on Apr 21, 2010 Female patient from FRANCE , 82 years of age, was treated with Tareg (View Usage). After Tareg was administered, patient had the following side effects: loss of consciousness, malaise, orthostatic hypotension. Tareg dosage: 80 Mg. During the same period patient was treated with CORVASAL (View Corvasal Review and Corvasal Label ), LASIX (View Lasix Review and Lasix Label ), IXPRIM (View Ixprim Review and Ixprim Label ), SEROPLEX (View Seroplex Review and Seroplex Label ), TAHOR (10 Mg) (View Tahor Review and Tahor Label ), DIFFU K (View Diffu K Review and Diffu K Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), MOPRAL (View Mopral Review and Mopral Label ). Patient was hospitalized.

6608707-2 | Depression, Personality Disorder
on Feb 17, 2010 Female patient from CHILE , 58 years of age, was diagnosed with hypertension and was treated with Tareg (View Usage). Patient experienced the following unwanted or unexpected effects: depression (What is depression?), personality disorder (What is personality disorder?). Tareg dosage: 1 Tablet (160 Mg) Per Day. During the same period patient was treated with CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), QUETIAPINE (View Quetiapine Review and Quetiapine Label ). Patient was hospitalized.

6606427-1 | Asthenia, Cholestasis, Faeces Discoloured, Liver Disorder, Nausea, Pruritus
Patient was taking Tareg (View Usage). Patient had the following side effects: asthenia, cholestasis, faeces discoloured, liver disorder, nausea (What is nausea?), pruritus on Feb 15, 2010 from FRANCE Additional patient health information: Male patient , 57 years of age, was diagnosed with hypertension and. Tareg dosage: 160 Mg, Qd.

6601088-X | Eye Operation
Adverse event was reported on Feb 12, 2010 by a Female patient taking Tareg (View Usage) (Dosage: 160mg, 1 Df Daily) was diagnosed with hypertension and. Location: CHILE , 79 years of age, After Tareg was administered, patient had the following side effects: eye operation. During the same period patient was treated with DEGRALER (View Degraler Review and Degraler Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ). Patient was hospitalized.

6582436-6 | Blood Creatine Phosphokinase Increased, Blood Creatine Phosphokinase Mb Increased, Infarction, Muscle Disorder, Myopathy
on Feb 03, 2010 Male patient from FRANCE , 64 years of age, was treated with Tareg (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, infarction, muscle disorder (What is muscle disorder?), myopathy. Tareg dosage: . During the same period patient was treated with TENORDATE (View Tenordate Review and Tenordate Label ), ZOCOR (10 Mg, Unk) (View Zocor Review and Zocor Label ), ZYLORIC (200 Mg, Unk) (View Zyloric Review and Zyloric Label ), LIPANOR (Unk) (View Lipanor Review and Lipanor Label ), FRACTAL (Unk) (View Fractal Review and Fractal Label ), CRESTOR (10 Mg, Unk) (View Crestor Review and Crestor Label ). Patient was hospitalized.

6569663-9 | Pharyngeal Oedema, Urticaria
on Jan 22, 2010 Female patient from FRANCE , weighting 127.9 lb, was diagnosed with hypertension, hypothyroidism, anxiety (What is anxiety?) and was treated with Tareg (View Usage). Patient had the following side effects: pharyngeal oedema, urticaria. Tareg dosage: 40 Mg, Qd. During the same period patient was treated with LEVOTHYROXINE SODIUM (100 Ug, Unk) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ALPRAZOLAM (0.25 Mg, Unk) (View Alprazolam Review and Alprazolam Label ).

6569655-X | Cough, Dysmenorrhoea, Ear Pain, Fatigue, Hypotension, Nasopharyngitis, Pain In Extremity, Rhinitis, Vertigo
Patient was taking Tareg (View Usage). After Tareg was administered, patient had the following side effects: cough, dysmenorrhoea, ear pain, fatigue, hypotension, nasopharyngitis, pain in extremity, rhinitis, vertigo on Jan 22, 2010 from FRANCE Additional patient health information: Female patient , weighting 92.59 lb, was diagnosed with microalbuminuria, renal transplant and. Tareg dosage: 40 Mg, Qd. During the same period patient was treated with IMUREL (100 Mg, Daily) (View Imurel Review and Imurel Label ), CORTANCYL (5 Mg, Daily) (View Cortancyl Review and Cortancyl Label ).

6521662-9 | Benign Prostatic Hyperplasia, Blood Immunoglobulin E Increased, Blood Pressure Increased, Blood Pressure Systolic, Lip Swelling, Urticaria
Adverse event was reported on Dec 18, 2009 by a Male patient taking Tareg (View Usage) (Dosage: 80) was diagnosed with hypertension and. Location: FRANCE , 77 years of age, weighting 169.8 lb, Patient experienced the following unwanted or unexpected effects: benign prostatic hyperplasia, blood immunoglobulin e increased, blood pressure increased, blood pressure systolic, lip swelling, urticaria. During the same period patient was treated with KARDEGIC (75) (View Kardegic Review and Kardegic Label ).

6503079-6 | Azotaemia, Hallucinations, Mixed, Hyperkalaemia, Leukocyturia, Renal Failure Acute
on Dec 07, 2009 Female patient from FRANCE , 67 years of age, was treated with Tareg (View Usage). Patient had the following side effects: azotaemia, hallucinations, mixed, hyperkalaemia, leukocyturia, renal failure acute. Tareg dosage: 160 Mg, Qd. During the same period patient was treated with ALDALIX (5/20 Mg Qd) (View Aldalix Review and Aldalix Label ), BI PROFENID (Unk) (View Bi-profenid Review and Bi-profenid Label ), TENORMIN (100 Mg, Qd) (View Tenormin Review and Tenormin Label ), SIMVASTATIN (10 Mg, Unk) (View Simvastatin Review and Simvastatin Label ), KESTINE (View Kestine Review and Kestine Label ), IXPRIM (3 Df Daily For 3 Weeks) (View Ixprim Review and Ixprim Label ). Patient was hospitalized.

6486949-7 | Eczema, Toxic Skin Eruption
on Nov 19, 2009 Male patient from FRANCE , 75 years of age, was treated with Tareg (View Usage). After Tareg was administered, patient had the following side effects: eczema (What is eczema?), toxic skin eruption. Tareg dosage: 80 Mg, Unk.

6480929-3 | Azotaemia, Blood Creatine Increased, Hallucinations, Mixed, Hyperkalaemia
Patient was taking Tareg (View Usage). Patient experienced the following unwanted or unexpected effects: azotaemia, blood creatine increased, hallucinations, mixed, hyperkalaemia on Nov 30, 2009 from FRANCE Additional patient health information: Female patient , 67 years of age, was diagnosed with back pain (What is back pain?) and. Tareg dosage: 160 Mg, Unk. During the same period patient was treated with IXPRIM (3 Df, Qd) (View Ixprim Review and Ixprim Label ), RISPERIDONE (2 Mg, Unk) (View Risperidone Review and Risperidone Label ), KESTINE (10 Mg, Unk) (View Kestine Review and Kestine Label ), ALDALIX (1 Df, Unk) (View Aldalix Review and Aldalix Label ), TENORMIN (100 Mg, Unk) (View Tenormin Review and Tenormin Label ), SIMVASTATIN (100 Mg, Unk) (View Simvastatin Review and Simvastatin Label ), BI PROFENID (View Bi-profenid Review and Bi-profenid Label ). Patient was hospitalized.

6471103-5 | Cataract Operation
Adverse event was reported on Nov 24, 2009 by a Female patient taking Tareg (View Usage) (Dosage: 160 Mg, Qd) was diagnosed with hypertension and. Location: CHILE , 93 years of age, Patient had the following side effects: cataract operation. During the same period patient was treated with GLAFORNIL (View Glafornil Review and Glafornil Label ).

6460257-2 | Blood Bilirubin Increased
on Nov 16, 2009 Male patient from FRANCE , 50 years of age, was treated with Tareg (View Usage). After Tareg was administered, patient had the following side effects: blood bilirubin increased. Tareg dosage: 160 Mg.

6446422-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Cholestasis, Cytolytic Hepatitis, Dyspnoea Exertional, Fatigue, Gamma-glutamyltransferase Increased, Hepatic Steatosis
on Nov 06, 2009 Female patient from FRANCE , weighting 149.9 lb, was diagnosed with oral contraception and was treated with Tareg (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, cholestasis, cytolytic hepatitis, dyspnoea exertional, fatigue, gamma-glutamyltransferase increased, hepatic steatosis. Tareg dosage: 40 Mg, Qd. During the same period patient was treated with LEVONORGESTREL AND ETHINYL ESTRADIOL (1 Df, Qd) (View Levonorgestrel And Ethinyl Estradiol Review and Levonorgestrel And Ethinyl Estradiol Label ).

6413549-7 | Angina Pectoris, Cardiac Pacemaker Insertion, Extrasystoles
Patient was taking Tareg (View Usage). Patient had the following side effects: angina pectoris, cardiac pacemaker insertion, extrasystoles on Oct 13, 2009 from CHILE Additional patient health information: Female patient , 79 years of age, was diagnosed with hypertension and. Tareg dosage: 1 Tablet (80 Mg ) Per Day. During the same period patient was treated with NEO SINTROM (1 Tablet Per Day) (View Neo-sintrom Review and Neo-sintrom Label ), DIGOXIN (1 Tablet Per Day) (View Digoxin Review and Digoxin Label ), HYDROCHLOROTHIAZIDE (1 Tablet Per Day) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

6398894-6 |
Adverse event was reported on Oct 08, 2009 by a Male patient taking Tareg (View Usage) (Dosage: 80 Mg, Unk) . Location: CHILE , 88 years of age, .

6393296-0 | Fall, Fibula Fracture, Nasopharyngitis, Surgery, Tibia Fracture
on Sep 24, 2009 Female patient from CHILE , 73 years of age, was diagnosed with hypertension and was treated with Tareg (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), fibula fracture, nasopharyngitis, surgery (What is surgery?), tibia fracture. Tareg dosage: 320 Mg, Qd. During the same period patient was treated with AMITRIPTYLINE (View Amitriptyline Review and Amitriptyline Label ). Patient was hospitalized.

6377913-7 | Carpal Tunnel Decompression, Spinal Operation
on Sep 16, 2009 Female patient from CHILE , 71 years of age, was diagnosed with hypertension and was treated with Tareg (View Usage). Patient had the following side effects: carpal tunnel decompression, spinal operation. Tareg dosage: 1 Df (80 Mg) Per Day. During the same period patient was treated with LEXAPRO (View Lexapro Review and Lexapro Label ), CRESTOR (View Crestor Review and Crestor Label ), UREN (View Uren Review and Uren Label ), PLAQUINOL (View Plaquinol Review and Plaquinol Label ), SUPRADYN (View Supradyn Review and Supradyn Label ). Patient was hospitalized.

6362092-2 | Cardio-respiratory Arrest
Patient was taking Tareg (View Usage). After Tareg was administered, patient had the following side effects: cardio-respiratory arrest on Sep 16, 2009 from CHILE Additional patient health information: Female patient , 89 years of age, was diagnosed with hypertension and. Tareg dosage: 160 Mg, Qd.

6358307-7 | Blood Creatinine Increased, Gastric Disorder, Rhinitis Allergic, White Blood Cell Count Decreased
Adverse event was reported on Sep 09, 2009 by a Female patient taking Tareg (View Usage) (Dosage: 180 Mg, Qd) was diagnosed with hypertension and. Location: CHILE , 70 years of age, Patient experienced the following unwanted or unexpected effects: blood creatinine increased, gastric disorder, rhinitis allergic, white blood cell count decreased. During the same period patient was treated with CALCIUM (View Calcium Review and Calcium Label ), LIVIAL (View Livial Review and Livial Label ).

6338996-3 | Cardiac Arrest, Respiratory Arrest
on Aug 28, 2009 Female patient from CHILE , 89 years of age, was diagnosed with hypertension and was treated with Tareg (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), respiratory arrest. Tareg dosage: 160 Mg, Qd.

6331634-5 | Eyelid Tumour, Neoplasm Malignant, Surgery
on Aug 19, 2009 Female patient from CHILE , 79 years of age, was treated with Tareg (View Usage). After Tareg was administered, patient had the following side effects: eyelid tumour, neoplasm malignant, surgery (What is surgery?). Tareg dosage: Unk.

6313990-7 | Urticaria
Patient was taking Tareg (View Usage). Patient experienced the following unwanted or unexpected effects: urticaria on Aug 10, 2009 from FRANCE Additional patient health information: Male patient , 78 years of age, weighting 176.4 lb, was diagnosed with hypertension and. Tareg dosage: 160 Mg, Qd. During the same period patient was treated with SINTROM (Unk) (View Sintrom Review and Sintrom Label ), ESOMEPRAZOLE (1 Df Daily) (View Esomeprazole Review and Esomeprazole Label ), CRESTOR (1 Df Daily) (View Crestor Review and Crestor Label ), ANTIVITAMIN K (View Antivitamin-k Review and Antivitamin-k Label ). Patient was hospitalized.

6312338-1 | Cerebrovascular Accident
Adverse event was reported on Aug 06, 2009 by a Female patient taking Tareg (View Usage) (Dosage: 160 Mg) . Location: CHILE , 67 years of age, Patient had the following side effects: cerebrovascular accident.

6310342-0 | Bradycardia, Fall, Hyperkalaemia, Muscular Weakness
on Aug 13, 2009 Female patient from FRANCE , 83 years of age, was diagnosed with hypertension and was treated with Tareg (View Usage). After Tareg was administered, patient had the following side effects: bradycardia, fall (What is fall?), hyperkalaemia, muscular weakness. Tareg dosage: 160 Mg, Qd. During the same period patient was treated with ALDACTONE (25 Mg, Bid) (View Aldactone Review and Aldactone Label ), ALDACTAZINE (1 Df, Qd) (View Aldactazine Review and Aldactazine Label ), DIFFU K (6 Df, Qd) (View Diffu K Review and Diffu K Label ). Patient was hospitalized.

6307622-1 | Arthralgia, Gait Disturbance, Hyperaesthesia, Pain In Extremity, Peripheral Vascular Disorder
on Jul 31, 2009 Male patient from FRANCE , weighting 152.1 lb, was diagnosed with prophylaxis and was treated with Tareg (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, gait disturbance, hyperaesthesia, pain in extremity, peripheral vascular disorder. Tareg dosage: 160 Mg, Bid.

6282985-4 | Coronary Artery Bypass
Patient was taking Tareg (View Usage). Patient had the following side effects: coronary artery bypass (What is coronary artery bypass?) on Jul 09, 2009 from CHILE Additional patient health information: Female patient , 60 years of age, was diagnosed with hypertension and. Tareg dosage: 1 Tablet/day. During the same period patient was treated with ENALAPRIL MALEATE (Unk) (View Enalapril Maleate Review and Enalapril Maleate Label ). Patient was hospitalized.

6260543-5 | Fall, Fibula Fracture, Nasopharyngitis, Surgery, Tibia Fracture
Adverse event was reported on Jun 22, 2009 by a Female patient taking Tareg (View Usage) (Dosage: 320 Mg, Qd) was diagnosed with hypertension and. Location: CHILE , 73 years of age, After Tareg was administered, patient had the following side effects: fall (What is fall?), fibula fracture, nasopharyngitis, surgery (What is surgery?), tibia fracture. During the same period patient was treated with AMITRIPTYLINE (View Amitriptyline Review and Amitriptyline Label ). Patient was hospitalized.

6259001-3 | Pneumonitis
on Jun 24, 2009 Female patient from CHILE , 78 years of age, was diagnosed with hypertension and was treated with Tareg (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonitis. Tareg dosage: 1 Df (80 Mg)/ Day. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ).

6258332-0 | Chest Pain, Hyperkalaemia, International Normalised Ratio Increased, Lung Infection, Renal Failure
on Jun 22, 2009 Female patient from FRANCE , 89 years of age, was treated with Tareg (View Usage). Patient had the following side effects: chest pain (What is chest pain?), hyperkalaemia, international normalised ratio increased, lung infection, renal failure. Tareg dosage: 1 Df, Qd. During the same period patient was treated with ALDALIX (1 Df, Qd) (View Aldalix Review and Aldalix Label ). Patient was hospitalized.

6185659-3 | Angina Pectoris, Extrasystoles
Patient was taking Tareg (View Usage). After Tareg was administered, patient had the following side effects: angina pectoris, extrasystoles on Apr 30, 2009 from CHILE Additional patient health information: Female patient , 79 years of age, was diagnosed with hypertension and. Tareg dosage: Unk. Patient was hospitalized.

6184117-X | Blood Creatinine Increased, Blood Urea Increased, Endocarditis Staphylococcal, Implantable Defibrillator Removal, Renal Failure Acute
Adverse event was reported on Apr 28, 2009 by a Male patient taking Tareg (View Usage) (Dosage: 80 Mg, Bid) was diagnosed with cardiac failure and. Location: FRANCE , 69 years of age, Patient experienced the following unwanted or unexpected effects: blood creatinine increased, blood urea increased, endocarditis staphylococcal, implantable defibrillator removal, renal failure acute. During the same period patient was treated with ALDACTONE (25 Mg, Qd) (View Aldactone Review and Aldactone Label ), DIGOXIN (0.25 Mg, Unk) (View Digoxin Review and Digoxin Label ), LASIX (40 Mg, Unk) (View Lasix Review and Lasix Label ), CARDENSIEL (2.5 Mg, Unk) (View Cardensiel Review and Cardensiel Label ), RIFADIN (View Rifadin Review and Rifadin Label ). Patient was hospitalized.

6162454-2 | Blood Creatinine Increased, Coombs Test Positive, Haemoglobinuria, Haemolysis, Haemolytic Anaemia, Lung Disorder, Refractory Anaemia
on Apr 14, 2009 Male patient from FRANCE , weighting 141.1 lb, was diagnosed with hypertension, anaemia and was treated with Tareg (View Usage). Patient had the following side effects: blood creatinine increased, coombs test positive, haemoglobinuria, haemolysis, haemolytic anaemia, lung disorder, refractory anaemia. Tareg dosage: 1 Df, Qd. During the same period patient was treated with CORDARONE (1 Df, Qd) (View Cordarone Review and Cordarone Label ), DETENSIEL (0.5 Df, Qd) (View Detensiel Review and Detensiel Label ), LEXOMIL (0.25 Df, Qd) (View Lexomil Review and Lexomil Label ), FERROUS SULFATE TAB (2 Df/day) (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), TAKETIAM (2 Df, Qd) (View Taketiam Review and Taketiam Label ). Patient was hospitalized.

6149089-2 | Fall, Head Injury, Malaise, Orthostatic Hypotension
on Mar 30, 2009 Female patient from FRANCE , 79 years of age, was treated with Tareg (View Usage). After Tareg was administered, patient had the following side effects: fall (What is fall?), head injury, malaise, orthostatic hypotension. Tareg dosage: 60 Mg Daily. During the same period patient was treated with MONICOR L.P. (20 Mg Daily) (View Monicor L.p. Review and Monicor L.p. Label ), LASIX (40 Mg Daily) (View Lasix Review and Lasix Label ), RISPERDAL (0.5 Mg Daily) (View Risperdal Review and Risperdal Label ), SOTALOL HYDROCHLORIDE (View Sotalol Hydrochloride Review and Sotalol Hydrochloride Label ), VASTAREL (2 Df Daily) (View Vastarel Review and Vastarel Label ). Patient was hospitalized.

6141957-0 | Blood Creatinine Increased, Gastric Disorder, Rhinitis Allergic, White Blood Cell Count Decreased
Patient was taking Tareg (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, gastric disorder, rhinitis allergic, white blood cell count decreased on Mar 25, 2009 from CHILE Additional patient health information: Female patient , 70 years of age, was diagnosed with hypertension and. Tareg dosage: 180 Mg, Qd. During the same period patient was treated with CALCIUM (View Calcium Review and Calcium Label ), LIVIAL (View Livial Review and Livial Label ).

6140291-2 | Anaemia, Condition Aggravated, Dermatitis Exfoliative, Eczema, Erythema, Lichenoid Keratosis, Lymphoma, Pruritus, Rash
Adverse event was reported on Mar 23, 2009 by a Male patient taking Tareg (View Usage) (Dosage: 160 Mg, Qd) was diagnosed with hypertension, gastric ulcer, prostate cancer (What is prostate cancer?) and. Location: FRANCE , 85 years of age, Patient had the following side effects: anaemia, condition aggravated, dermatitis exfoliative, eczema (What is eczema?), erythema, lichenoid keratosis, lymphoma (What is lymphoma?), pruritus, rash (What is rash?). During the same period patient was treated with OGAST (1 Df, Qd) (View Ogast Review and Ogast Label ), DECAPEPTYL /SCH/ (1 Df Every 3 Months) (View Decapeptyl /sch/ Review and Decapeptyl /sch/ Label ), AMLODIPINE BESYLATE (5 Mg, Bid) (View Amlodipine Besylate Review and Amlodipine Besylate Label ). Patient was hospitalized.

6111234-2 | Herpes Zoster
on Feb 26, 2009 Female patient from FRANCE , weighting 141.1 lb, was diagnosed with hypertension and was treated with Tareg (View Usage). After Tareg was administered, patient had the following side effects: herpes zoster. Tareg dosage: 80 Mg, Qd.

6110558-2 | Arthralgia, Herpes Zoster, Middle Insomnia, Tenosynovitis
on Feb 26, 2009 Female patient from FRANCE , weighting 141.1 lb, was diagnosed with hypertension and was treated with Tareg (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, herpes zoster, middle insomnia, tenosynovitis. Tareg dosage: 80 Mg, Qd. During the same period patient was treated with DOLIPRANE (Unk) (View Doliprane Review and Doliprane Label ).

6107131-9 | Fall, Humerus Fracture, Immobilisation Prolonged
Patient was taking Tareg (View Usage). Patient had the following side effects: fall (What is fall?), humerus fracture, immobilisation prolonged on Feb 23, 2009 from FRANCE Additional patient health information: Female patient , 81 years of age, . Tareg dosage: 160 Mg, Qd. During the same period patient was treated with LOXEN LP (50 Mg, Qd) (View Loxen Lp Review and Loxen Lp Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), DIAMICRON (60 Mg Daily) (View Diamicron Review and Diamicron Label ), TANAKAN (View Tanakan Review and Tanakan Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ACTONEL (View Actonel Review and Actonel Label ). Patient was hospitalized.